METHODS: The literature inclusion criteria were (1) critically ill patients, (2) device-related pressure injury interventions, (3) randomized controlled trials and quasi-experimental designs, and (4) written in Korean or English. The literature search and selection were performed following the Cochrane Handbook for Systematic Reviews of Interventions with the support of the PRISMA Guidelines.
RESULTS: Twelve articles were finally selected. The incidence of medical device-related pressure injury decreased from 8.1-96.7% before intervention to 0.3-53.3% after intervention, respectively. Medical device-related pressure injury prevention was effective in reducing medical device-related pressure injury incidence when applied to patients of all ages, from neonates to adults, in a variety of intensive care units. Medical device-related pressure injury prevention strategies include nurse education, assessment, documentation, and interventions (hygiene, repositioning, emergent therapy such as protective dressing or designed equipment reducing pressure) of pressure injury. Pressure injury dressings primarily included hydrocolloid foam dressings, but transparent hydrocolloid formulations also effectively reduced medical device-related pressure injury incidence rates.
CONCLUSIONS: In the future, it is necessary to increase the level of evidence by applying specialized medical device-related pressure injury prevention methods for different medical devices and areas of pressure injuries, and verifying their effectiveness.
BACKGROUND: The review protocol was registered (PROSPERO registration number: CRD42022346450).
方法:文献纳入标准为(1)危重患者,(2)与设备相关的压力伤害干预措施,(3)随机对照试验和准实验设计,和(4)用韩语或英语写的。在PRISMA指南的支持下,根据Cochrane干预措施系统审查手册进行文献检索和选择。
结果:最终选择了12篇文章。医疗器械相关压力性损伤的发生率从干预前的8.1-96.7%下降到干预后的0.3-53.3%,分别。医疗器械相关压力性损伤预防应用于各年龄段患者均能有效降低医疗器械相关压力性损伤发生率,从新生儿到成人,在各种重症监护病房。与医疗器械相关的压力性损伤预防策略包括护士教育,评估,文档,和干预措施(卫生,重新定位,紧急治疗,如保护性敷料或设计的减压设备)压力损伤。压力损伤敷料主要包括水胶体泡沫敷料,但透明的水胶体配方也有效降低了医疗器械相关压力损伤的发生率。
结论:在未来,有必要通过针对不同的医疗设备和压力伤害领域应用专门的与医疗设备相关的压力伤害预防方法来提高证据水平,并验证其有效性。
背景:审查协议已注册(PROSPERO注册号:CRD42022346450)。